Boost Your Productivity!Translate documents (Ms-Word, Ms-Excel, ...) faster and better thanks to artificial intelligence!
https://pro.wordscope.com
https://blog. wordscope .com

Vertaling van "25 11 1997 " (Nederlands → Frans) :

1 C10AA05 ATORVASTATINE 87.300.930 145.589.958 260.380 1 12,5% 1998 2 A02BC01 OMEPRAZOL 62.340.992 95.843.923 620.201 4 0,0% 1989 3 C10AA01 SIMVASTATINE 49.611.106 128.763.793 305.775 2 9,3% 1990 4 R03AK06 SALMETEROL MET EEN CORICOSTEROID 47.041.795 31.693.401 231.380 20 - 2001 5 B01AC04 CLOPIDOGREL 40.392.860 22.695.745 88.653 42 - 2001 6 C10AA03 PRAVASTATINE 38.944.967 51.049.165 107.888 11 15,9% 1993 7 C08CA01 AMLODIPINE 38.173.620 84.814.224 240.903 6 3,6% 1990 8 C01DX12 MOLSIDOMINE 33.821.119 96.832.255 153.999 3 5,4% 1981 9 N06AB05 PAROXETINE 32.249.511 35.519.220 196.430 14 6,5% 1993 10 M05BA04 ALENDRONINEZUUR 32.093.059 30.506.04 ...[+++]

1 C10AA05 ATORVASTATINE 87.300.930 145.589.958 260.380 1 12,5% 1998 2 A02BC01 OMEPRAZOLE 62.340.992 95.843.923 620.201 4 0,0% 1989 3 C10AA01 SIMVASTATINE 49.611.106 128.763.793 305.775 2 9,3% 1990 4 R03AK06 SALMETEROL AVEC UN CORTICOSTEROIDE 47.041.795 31.693.401 231.380 20 - 2001 5 B01AC04 CLOPIDOGREL 40.392.860 22.695.745 88.653 42 - 2001 6 C10AA03 PRAVASTATINE 38.944.967 51.049.165 107.888 11 15,9% 1993 7 C08CA01 AMLODIPINE 38.173.620 84.814.224 240.903 6 3,6% 1990 8 C01DX12 MOLSIDOMINE 33.821.119 96.832.255 153.999 3 5,4% 1981 9 N06AB05 PAROXETINE 32.249.511 35.519.220 196.430 14 6,5% 1993 10 M05BA04 ACIDE ALENDRONIQUE 32.093.059 30. ...[+++]


1974 on the opening, transfer and merger of retail pharmacies Royal decree of 9 July 1984 on the provision of information and advertising relating to medicines Royal decree of 11 January 1993 determining the conditions under which medicines for human use may be supplied in sample form Royal decree of 7 April 1995 on the provision of information and advertising relating to medicines for human use Royal decree of 15 July 1997 on active implantable medical devices, transposing Directive 90/385 EEC (AIMD) Royal decree of 19 December 1997 on the control and analysis of the raw materials used by dispensing chemists Royal decree of 18 March 199 ...[+++]

1974 on the opening, transfer and merger of retail pharmacies Royal decree of 9 July 1984 on the provision of information and advertising relating to medicines Royal decree of 11 January 1993 determining the conditions under which medicines for human use may be supplied in sample form Royal decree of 7 April 1995 on the provision of information and advertising relating to medicines for human use Royal decree of 15 July 1997 on active implantable medical devices, transposing Directive 90/385 EEC (AIMD) Royal decree of 19 December 1997 on the control and analysis of the raw materials used by dispensing chemists Royal decree of 18 March 199 ...[+++]


1 C10AA05 ATORVASTATINE 85.561.314 158.173.292 259.787 2 2.113.588 1998 2 A02BC01 OMEPRAZOL 52.538.689 109.540.232 612.450 3 336.723 1989 3 C10AA01 SIMVASTATINE 47.666.132 250.068.372 516.779 1 492.318 1990 4 B01AC04 CLOPIDOGREL 47.486.130 31.967.419 117.883 25 5.865.672 2001 5 R03AK06 SALMETEROL MET EEN CORTICOSTEROID 45.200.481 27.136.457 211.191 37 2.061.624 2001 6 L04AB01 ETANERCEPT 38.436.521 957.065 3.980 300 7.665.401 2002 7 A02BC02 PANTOPRAZOL 37.409.165 25.785.995 177.765 39 3.308.748 1997 8 B02BD02 BLOEDSTOLLINGSFACTOR VIII (ANTIHEMOFILIEFACTOR A) 36.453.099 75.773 224 517 3.451.406 1980 9 N06AX16 VENLAFAXINE 34.506.172 28.835. ...[+++]

1 C10AA05 ATORVASTATINE 85.561.314 158.173.292 259.787 2 2.113.588 1998 2 A02BC01 OMEPRAZOLE 52.538.689 109.540.232 612.450 3 336.723 1989 3 C10AA01 SIMVASTATINE 47.666.132 250.068.372 516.779 1 492.318 1990 4 B01AC04 CLOPIDOGREL 47.486.130 31.967.419 117.883 25 5.865.672 2001 5 R03AK06 SALMETEROL AVEC UN CORTICOSTEROIDE 45.200.481 27.136.457 211.191 37 2.061.624 2001 6 L04AB01 ETANERCEPT 38.436.521 957.065 3.980 300 7.665.401 2002 7 A02BC02 PANTOPRAZOLE 37.409.165 25.785.995 177.765 39 3.308.748 1997 8 B02BD02 FACTEUR VIII DE COAGULATION 36.453.099 75.773 224 517 3.451.406 1980 9 N06AX16 VENLAFAXINE 34.506.172 28.835.615 129.329 34 2.64 ...[+++]


In zijn vergadering van 18 oktober 1997 beëindigde de Nationale Raad het onderzoek van uw brieven de dato 3 maart, 11 en 25 april 1997.

Le Conseil national a, en sa séance du 18 octobre 1997, achevé l'examen de vos lettres des 3 mars, 11 et 25 avril 1997.


1 C10AA05 ATORVASTATINE 86.029.822 147.256.488 254.952 2 7,1% 1998 2 A02BC01 OMEPRAZOL 52.408.016 98.230.445 600.315 3 -3,6% 1980 3 C10AA01 SIMVASTATINE 50.096.726 184.526.496 402.691 1 5,3% 1990 4 B01AC04 CLOPIDOGREL 47.930.575 27.415.057 104.165 31 71,3% 2001 5 R03AK06 SALMETEROL MET EEN CORTICOSTEROID 46.757.791 32.090.329 230.604 21 77,2% 2001 6 C01DX12 MOLSIDOMINE 33.517.991 96.934.598 146.382 4 4,0% 1981 7 M05BA04 ALENDRONINEZUUR 32.567.363 31.292.636 108.353 23 20,3% 1998 8 N06AX16 VENLAFAXINE 32.157.773 25.902.246 133.592 36 17,4% 1997 9 A02BC02 PANTOPRAZ ...[+++]

1 C10AA05 ATORVASTATINE 86.029.822 147.256.488 254.952 2 7,1% 1998 2 A02BC01 OMEPRAZOLE 52.408.016 98.230.445 600.315 3 -3,6% 1980 3 C10AA01 SIMVASTATINE 50.096.726 184.526.496 402.691 1 5,3% 1990 4 B01AC04 CLOPIDOGREL 47.930.575 27.415.057 104.165 31 71,3% 2001 5 R03AK06 SALMETEROL AVEC UN CORTICOSTEROIDE 46.757.791 32.090.329 230.604 21 77,2% 2001 6 C01DX12 MOLSIDOMINE 33.517.991 96.934.598 146.382 4 4,0% 1981 7 M05BA04 ACIDE ALENDRONIQUE 32.567.363 31.292.636 108.353 23 20,3% 1998 8 N06AX16 VENLAFAXINE 32.157.773 25.902.246 133.592 36 17,4% 1997 9 A02BC02 ...[+++]


tot erkenning van de laboratoria voor ontleding van en controle op de geneesmiddelen Koninklijk besluit van 6 juni 1960 betreffende de fabricage, de bereiding en distributie in het groot en de terhandstelling van geneesmiddelen Koninklijk besluit nr. 78 van 10 november 1967 betreffende de uitoefening van de gezondheidszorgberoepen wat betreft de aflevering van geneesmiddelen aan het publiek en het koninklijk besluit van 25 september 1974 betreffende de opening, de overbrenging en de fusie van voor het publiek opengestelde apotheken Koninklijk besluit van 9 juli 1984 betreffende de voorlichting en de reclame inzake geneesmiddelen Koninklijk besluit van 11 januari 1993 tot vaststelling van de voorwaarden waaronder geneesmiddelen voor menselij ...[+++]

Arrêté royal n° 78 du 10 novembre 1967 relatif à l’exercice des professions des soins de santé en ce qui concerne la délivrance de médicaments au public et l’arrêté royal du 25 septembre 1974 concernant l’ouverture, le transfert et la fusion d’officines pharmaceutiques ouvertes au public Arrêté royal du 9 juillet 1984 relatif à l’information et à la publicité concernant les médicaments Arrêté royal du 11 janvier 1993 fixant les conditions dans lesquelles la remise de médicaments à usage humain sous forme d’échantillons peut être effectuée Arrêté royal du 7 avril 1995 relatif à l’information et à la publicité concernant les médicaments à usage humain Arrêté royal du 15 juillet 1997 ...[+++]


1 C10AA05 ATORVASTATINE 80.686.584 146.899.233 251.820 2 2% 1998 2 B01AC04 CLOPIDOGREL 47.609.277 30.244.418 113.011 27 27% 2001 3 R03AK06 SALMETEROL MET EEN CORTICOSTEROID 44.577.901 31.013.408 207.593 25 6% 2001 4 C10AA01 SIMVASTATINE 43.269.689 219.557.941 466.220 1 -1% 1990 5 A02BC01 OMEPRAZOL 42.683.976 86.292.134 500.152 5 -4% 1980 6 A02BC02 PANTOPRAZOL 34.695.179 23.683.199 176.992 44 14% 1980 7 B02BD02 BLOEDSTOLLINGSFACTOR VIII (ANTIHEMOFILIEFACTOR A) 33.984.254 70.418 234 519 15% 1980 8 L04AA11 ETANERCEPT 33.566.248 834.160 3.479 309 - 2002 9 N06AX16 VENLAFAXINE 32.739.744 27.191.385 127.232 35 11% 1997 10 C01DX12 MOLSIDOMINE 31 ...[+++]

1 C10AA05 ATORVASTATINE 80.686.584 146.899.233 251.820 2 2% 1998 2 B01AC04 CLOPIDOGREL 47.609.277 30.244.418 113.011 27 27% 2001 3 R03AK06 SALMETEROL AVEC UN CORTICOSTEROIDE 44.577.901 31.013.408 207.593 25 6% 2001 4 C10AA01 SIMVASTATINE 43.269.689 219.557.941 466.220 1 -1% 1990 5 A02BC01 OMEPRAZOLE 42.683.976 86.292.134 500.152 5 -4% 1980 6 A02BC02 PANTOPRAZOLE 34.695.179 23.683.199 176.992 44 14% 1980 7 B02BD02 FACTEUR VIII DE COAGULATION 33.984.254 70.418 234 519 15% 1980 8 L04AA11 ETANERCEPT 33.566.248 834.160 3.479 309 - 2002 9 N06AX16 VENLAFAXINE 32.739.744 27.191.385 127.232 35 11% 1997 10 C01DX12 MOLSIDOMINE 31.933.364 94.529.527 140 ...[+++]


ATC Chemische subgroep 1997 1998 1999 2000 2001 2002 2003 2004 2005 J01CR02 AMOXICILLINE MET ENZYMREMMER 14.111.874 15.023.840 15.330.154 15.415.701 15.394.955 17.045.550 19.905.047 19.342.248 20.810.492 J01CA04 AMOXICILLINE 10.821.714 11.147.328 11.442.513 10.563.314 9.049.524 10.045.679 10.296.701 10.645.005 13.821.274 Totaal 24.933.588 26.171.168 26.772.667 25.979.015 24.444.479 27.091.228 30.201.748 29.987.252 34.631.766 In % van totaal J01CR02 AMOXICILLINE MET ENZYMREMMER 56,6% 57,4% 57,3% 59,3% 63,0% 62,9% 65,9% 64,5% 60,1% J01C ...[+++]

ATC Groupe de médicaments 1997 1998 1999 2000 2001 2002 2003 2004 2005 J01CR02 AMOXICILLINE ET INHIBITEURS D'ENZYME 14.111.874 15.023.840 15.330.154 15.415.701 15.394.955 17.045.550 19.905.047 19.342.248 20.810.492 J01CA04 AMOXICILLINE 10.821.714 11.147.328 11.442.513 10.563.314 9.049.524 10.045.679 10.296.701 10.645.005 13.821.274 Total 24.933.588 26.171.168 26.772.667 25.979.015 24.444.479 27.091.228 30.201.748 29.987.252 34.631.766 In % van totaal J01CR02 AMOXICILLINE ET INHIBITEURS D'ENZYME 56,6% 57,4% 57,3% 59,3% 63,0% 62,9% 65,9 ...[+++]


1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 20-24 52,17% 49,96% 49,58% 50,04% 50,61% 51,10% 52,54% 52,49% 51,39% 50,57% 25-29 73,64% 74,46% 75,32% 76,14% 76,60% 76,54% 76,57% 77,16% 78,30% 79,29% 30-34 66,07% 66,38% 66,86% 67,90% 68,86% 69,72% 71,39% 72,68% 73,72% 74,11% 35-39 56,91% 57,19% 58,24% 59,41% 61,15% 62,60% 63,83% 64,90% 65,96% 67,10% 40-44 48,26% 49,42% 50,66% 52,07% 53,97% 55,65% 56,83% 58,57% 59,87% 61,78% 45-49 40,30% 41,46% 41,69% 43,80% 45,65% 47,78% 49,76% 51,61% 53,10% 55,31% 50-54 31,49% 33,24% 36,54% 37,63% 38,55% 39,54% 41,22% 41,91% 44,09% 46,18% 55-59 21,42% 21,93% 22,47% 23,85% 26,36% 28,89% 31,18% 34,48% 3 ...[+++]

1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 20-24 52,17% 49,96% 49,58% 50,04% 50,61% 51,10% 52,54% 52,49% 51,39% 50,57% 25-29 73,64% 74,46% 75,32% 76,14% 76,60% 76,54% 76,57% 77,16% 78,30% 79,29% 30-34 66,07% 66,38% 66,86% 67,90% 68,86% 69,72% 71,39% 72,68% 73,72% 74,11% 35-39 56,91% 57,19% 58,24% 59,41% 61,15% 62,60% 63,83% 64,90% 65,96% 67,10% 40-44 48,26% 49,42% 50,66% 52,07% 53,97% 55,65% 56,83% 58,57% 59,87% 61,78% 45-49 40,30% 41,46% 41,69% 43,80% 45,65% 47,78% 49,76% 51,61% 53,10% 55,31% 50-54 32,39% 34,09% 37,32% 38,18% 39,01% 39,98% 41,63% 42,24% 44,40% 46,55% 55-59 25,62% 25,99% 26,44% 27,89% 29,79% 31,84% 33,85% 37,06% 3 ...[+++]


1985 14 469 / 11 506 1986 15 431 13 075 12 109 1990 19 028 16 571 14 269 1995 23 347 19 774 16 102 1996 24 331 20 481 16 342 1997 24 286 20 562 16 694 1998 25 009 21 254 17 233 1999 26 050 22 128 17 886 2000 27 053 22 923 18 475 2001 27 362 23 323 18 580 2002 27 475 22 007 / (*) Op 31 december van het onderzochte jaar (**) Op basis van de tijdens het onderzochte jaar geboekte gegevens Bron : RIZIV – Dienst voor geneeskundige verzorging

1985 14 469 / 11 506 1986 15 431 13 075 12 109 1990 19 028 16 571 14 269 1995 23 347 19 774 16 102 1996 24 331 20 481 16 342 1997 24 286 20 562 16 694 1998 25 009 21 254 17 233 1999 26 050 22 128 17 886 2000 27 053 22 923 18 475 2001 27 362 23 323 18 580 2002 27 475 22 007 / (*) Au 31 décembre de l’année considérée (**) Sur base des données comptabilisées au cours de l’année considérée Source : INAMI – Service des soins de santé




Anderen hebben gezocht naar : july     oktober     juli     chemische subgroep     25 11 1997     


datacenter (28): www.wordscope.be (v4.0.br)

'25 11 1997' ->

Date index: 2025-01-26
w